Dr. Sakamoto explains signaling pathways in the pathogenesis of diamond blackfan anemia

December 16, 2016

Diamond Blackfan Anemia (DBA) is a condition that is characterized by a failure of the bone marrow to produce red blood cells, congenital abnormalities, and a predisposition to cancer. Current treatment options, including steroid treatments and chronic transfusions, can lead to significant morbidity. Therefore, investigation into molecular mechanisms that drive DBA is critical to saving the lives of patients suffering from this disease.

DBA is caused by a deficiency of some ribosomal proteins to properly process pre-ribosomal ribonucleic acid (RNA), which is ultimately important for the translation of the genome into functional proteins. While it is known that p53, an important DNA repair protein, mediates many facets of DBA, its mechanism has not, until now, been well understood. With support from a Bone Marrow Failure Research Program FY12 Idea Award, Dr. Kathleen Sakamoto and her team at Stanford University has identified that a deficiency in RPS19, the most commonly mutated ribosomal protein in DBA patients, leads to the upregulation and activation of the p53 pathway. Furthermore, they have identified that a target of p53, microRNA34A, is responsible for decreased red blood cell formation.

In a recently published article in Disease Models & Mechanisms, Dr. Sakamoto's team used a zebrafish model of DBA with RPS19 and RPL11 insufficiency to further characterize the link between defects in ribosome biogenesis, nucleotide metabolism, and the p53 pathway in DBA. The RPS19-deficient zebrafish showed a decrease in proliferation, enhanced activation of the ATR/ATM-CHK1/CHK2/p53 DNA damage pathway, an imbalanced pool of nucleotides, ATP depletion, and AMPK activation. These findings are all hallmarks of cellular energy crisis,DNA replication stress, and thus enhanced DNA repair. When treating zebrafish with exogenous nucleosides, a decrease in the activation of p53 and AMPK was observed. As blood cells are highly dependent on salvage pathways for the production of nucleotides and are therefore vulnerable to a stressed metabolism, red blood cells in DBA patients may benefit from exogenous nucleosides. Nucleoside supplements are known to be very safe and are even included in many infant formulas. This form of supplementation may be beneficial, not only in patients with DBA, but also for other conditions that involve the activation of the DNA damage response, such as radiation exposure. Furthermore, treatment of the RP-deficient zebrafish with inhibitors of various cell cycle checkpoint kinases decreased p53 upregulation and apoptosis while resulting in an improvement of hematopoiesis. Therefore drugs that work to decrease DNA damage or help increase DNA repair could be effective for the treatment of DBA.

The results from this research have shed light on a previously undiscovered link between the well-studied p53 pathway and the lesser known pathways associated with ribosome biogenesis and nucleotide metabolism in DBA. Uncovering this link may provide several avenues for new treatment options for patients suffering from DBA and its current treatment regimens.

US Department of Defense Congressionally Directed Medical Research Programs

Related Bone Marrow Articles from Brightsurf:

Researchers identify the mechanism behind bone marrow failure in Fanconi anaemia
Researchers at the University of Helsinki and the Dana-Farber Cancer Institute have identified the mechanism behind bone marrow failure developing in children that suffer from Fanconi anaemia.

Nanoparticles can turn off genes in bone marrow cells
Using specialized nanoparticles, MIT engineers have developed a way to turn off specific genes in cells of the bone marrow, which play an important role in producing blood cells.

How stress affects bone marrow
Researchers from Tokyo Medical and Dental University (TMDU) identified the protein CD86 as a novel marker of infection- and inflammation-induced hematopoietic responses.

3D atlas of the bone marrow -- in single cell resolution
Stem cells located in the bone marrow generate and control the production of blood and immune cells.

Dangerous bone marrow, organ transplant complication explained
Scientists have discovered the molecular mechanism behind how the common cytomegalovirus can wreak havoc on bone marrow and organ transplant patients, according to a paper published in the journal Cell & Host Microbe.

Viagra shows promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem cells for bone marrow transplants using a combination of Viagra and a second drug called Plerixafor.

Bone marrow may be the missing piece of the fertility puzzle
A woman's bone marrow may determine her ability to start and sustain a pregnancy, report Yale researchers in PLOS Biology.

Cells that make bone marrow also travel to the womb to help pregnancy
Bone marrow-derived cells play a role in changes to the mouse uterus before and during pregnancy, enabling implantation of the embryo and reducing pregnancy loss, according to research published Sept.

Uncovering secrets of bone marrow cells and how they differentiate
Researchers mapped distinct bone marrow niche populations and their differentiation paths for the bone marrow factory that starts from mesenchymal stromal cells and ends with three types of cells -- fat cells, bone-making cells and cartilage-making cells.

Zebrafish help researchers explore alternatives to bone marrow donation
UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need for bone marrow donation.

Read More: Bone Marrow News and Bone Marrow Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.